Journal
CLINICAL BIOCHEMISTRY
Volume 41, Issue 18, Pages 1489-1492Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.clinbiochem.2008.08.087
Keywords
Cystic fibrosis; Exocrine pancreatic insufficiency; (13)C-labeled mixed triglycerides; Breath test; Elastase; Faecal fat
Categories
Funding
- American College of Gastroenterology
Ask authors/readers for more resources
The MTG-BT estimates the hydrolysis of triacyl-glycerols by pancreatic lipase, and appears attractive for monitoring exogenous lipase requirements in patients with exocrine pancreatic insufficiency. To assess the test's discrimination capacity and repeatability. 9 CF patients with PERT and healthy children underwent the (13)C-MTG-BT twice, at a 2- to 4-week interval. The test distinguished well between patients with severe exocrine pancreatic insufficiency (SEPI) and healthy subjects. However, within-subject variability for postprandial parts per thousand (13)C-enrichment and postprandial % dose recovery (PDR) was high in both groups. Therefore, the (13)C-MTG-BT seems useful to distinguish between SEPI and normal exocrine pancreatic function. but requires further development to improve its repeatability. Crown Copyright (c) 2008 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available